Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants

Am J Obstet Gynecol. 1997 Jul;177(1):50-6. doi: 10.1016/s0002-9378(97)70437-x.

Abstract

Objective: We examined the effect of exposure to amniotic fluid infection and cytokines on the pulmonary outcome of preterm infants.

Study design: A cohort of 136 preterm infants born to women in preterm labor had amniotic fluid cultures and tumor necrosis factor-alpha assays performed. Amniotic fluid was collected by transabdominal amniocentesis. Outcome measures included respiratory distress syndrome and length of oxygen and ventilator support. Logistic regression and Cox proportional hazards regression adjusted for birth weight and other confounders.

Results: Respiratory distress syndrome developed in 67 (49%) of 136 infants. Elevated amniotic fluid tumor necrosis factor-alpha levels and amniotic fluid infection were significantly associated with respiratory distress syndrome. This association persisted after adjustment for birth weight. Infants exposed to tumor necrosis factor-alpha remained on supplemental oxygen and assisted ventilation longer and had longer hospital stays compared with nonexposed infants.

Conclusion: Prenatal exposure to tumor necrosis factor-alpha may be a risk factor for respiratory distress syndrome and its complications.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amniocentesis
  • Amniotic Fluid / chemistry*
  • Amniotic Fluid / microbiology
  • Cohort Studies
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature / physiology*
  • Length of Stay
  • Pregnancy
  • Prospective Studies
  • Regression Analysis
  • Respiration, Artificial
  • Respiratory Distress Syndrome, Newborn / epidemiology*
  • Respiratory Distress Syndrome, Newborn / etiology
  • Respiratory Distress Syndrome, Newborn / therapy
  • Risk Factors
  • Tumor Necrosis Factor-alpha / analysis*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Tumor Necrosis Factor-alpha